Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,631 | 75 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $646.13 | 18 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $486.78 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $280.25 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $266.61 | 8 | $0 (2021) |
| Amgen Inc. | $207.29 | 9 | $0 (2022) |
| Abbott Laboratories | $166.12 | 2 | $0 (2023) |
| Boston Scientific Corporation | $135.11 | 8 | $0 (2020) |
| Gilead Sciences Inc | $125.00 | 1 | $0 (2017) |
| PFIZER INC. | $114.65 | 6 | $0 (2021) |
| Amarin Pharma Inc. | $95.68 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $166.12 | 2 | Abbott Laboratories ($166.12) |
| 2022 | $38.79 | 2 | Amgen Inc. ($19.79) |
| 2021 | $545.81 | 20 | Janssen Pharmaceuticals, Inc ($173.81) |
| 2020 | $236.23 | 14 | Boston Scientific Corporation ($48.93) |
| 2019 | $268.71 | 13 | Janssen Pharmaceuticals, Inc ($137.02) |
| 2018 | $728.37 | 12 | Janssen Pharmaceuticals, Inc ($273.69) |
| 2017 | $647.07 | 12 | Novartis Pharmaceuticals Corporation ($216.21) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2023 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Structural Heart | ||||||
| 06/16/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $142.11 | General |
| Category: Vascular | ||||||
| 04/21/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiology | ||||||
| 02/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2021 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/20/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiology | ||||||
| 08/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/07/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiology | ||||||
| 05/06/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiovascular | ||||||
| 03/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiology | ||||||
| 02/17/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/07/2021 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiology | ||||||
| 12/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,475 | 1,648 | $404,782 | $88,890 |
| 2022 | 10 | 1,045 | 1,183 | $515,465 | $74,020 |
| 2021 | 13 | 1,429 | 1,894 | $1.4M | $196,745 |
| 2020 | 12 | 1,441 | 1,894 | $1.4M | $199,549 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 708 | 736 | $200,928 | $42,367 | 21.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 76 | $58,909 | $11,763 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 141 | $38,916 | $10,285 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 61 | $24,217 | $6,044 | 25.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 37 | 37 | $15,133 | $3,964 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 25 | $10,525 | $2,901 | 27.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 105 | 114 | $10,844 | $2,549 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $10,272 | $2,220 | 21.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $8,825 | $1,958 | 22.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 227 | 254 | $8,128 | $1,900 | 23.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 19 | $7,521 | $1,776 | 23.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 35 | $2,380 | $463.32 | 19.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 37 | 41 | $1,148 | $269.78 | 23.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 16 | 17 | $1,156 | $269.11 | 23.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 53 | 60 | $5,880 | $160.11 | 2.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 450 | 465 | $133,721 | $28,176 | 21.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 131 | 131 | $228,538 | $16,753 | 7.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 119 | $33,614 | $7,518 | 22.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $31,008 | $6,484 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 80 | $42,400 | $5,542 | 13.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $12,245 | $2,899 | 23.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 85 | 103 | $10,058 | $2,284 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 27 | $10,260 | $1,521 | 14.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 13 | 14 | $6,575 | $1,330 | 20.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 130 | 156 | $4,992 | $1,178 | 23.6% |
About Dr. Divya Malhotra, MD
Dr. Divya Malhotra, MD is a Cardiovascular Disease healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255420568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Divya Malhotra, MD has received a total of $2,631 in payments from pharmaceutical and medical device companies, with $166.12 received in 2023. These payments were reported across 75 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,631).
As a Medicare-enrolled provider, Malhotra has provided services to 5,390 Medicare beneficiaries, totaling 6,619 services with total Medicare billing of $559,204. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Goshen, NY
- Active Since 10/12/2006
- Last Updated 10/19/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255420568
Products in Payments
- XARELTO (Drug) $646.13
- ENTRESTO (Drug) $486.78
- PRADAXA (Drug) $207.99
- MITRACLIP (Device) $142.11
- FARXIGA (Drug) $135.55
- BRILINTA (Drug) $131.06
- Ranexa (Drug) $125.00
- ELIQUIS (Drug) $114.65
- Vascepa (Drug) $95.68
- Repatha (Biological) $81.18
- JARDIANCE (Drug) $72.26
- Corlanor (Drug) $49.43
- LATITUDE (Device) $33.87
- RESONATE (Device) $33.63
- EMBLEM (Device) $28.57
- NORTHERA (Drug) $24.57
- AMPLATZER AMULET (Device) $24.01
- Yupelri (Drug) $20.00
- Flexitouch Plus (Device) $17.66
- LEXISCAN (Drug) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Goshen
Dr. Inderpal Singh, Md, MD
Cardiovascular Disease — Payments: $375,728
Blair Macphail, Md, MD
Cardiovascular Disease — Payments: $11,130
Dr. Farid Jalinous, M.d, M.D
Cardiovascular Disease — Payments: $8,841
Dr. Djavid Hadian, M.d, M.D
Cardiovascular Disease — Payments: $6,566
Dr. Viral Sheth, Md, MD
Cardiovascular Disease — Payments: $3,853
Sreenivas Kamath, Md, MD
Cardiovascular Disease — Payments: $3,339